One key step on the path to value-based contracting (VBC) often ignored is the role of patient participation in achieving desired outcomes.

Better understanding of patient behaviors, such as adherence and lifestyle, is vital in achieving successful outcomes – so how do we better educate and incorporate patients into VBC programmes?
We need sensible patient inclusion.

Join eyeforpharma, Novartis, Evidation Health and more TBA to discuss the roadmap to achieve these changes.

Sign up to this free webinar here: https://goo.gl/aEM7Ui

Key learnings include:

• The impact patient adherence and lifestyle on meeting outcomes needed for VBC’s
• Insights into behavior using patient-centred digital tools
• Expand access to patient-provided data in full consent of modern privacy regulations
• Make patient consent the new norm, with exploration of what’s needed to improve public perception of data use

Join them on the 10th July at 1pm EST/10am PST, and don’t worry if you can’t attend live, they will send you the recordings anyway.

Sign up here: https://goo.gl/aEM7Ui

Getting patient support programs right can mean the difference between success or failure. It’s not about putting more money into it; they require upfront insight, design and ambition. Pills alone are not enough to meet the needs of patients and customers.
eyeforpharma’s latest whitepaper discusses how patient interactions can be increasingly personalized with support specific to each patient’s condition, circumstances and behavioral challenges. Get this right and you can positively impact patient outcomes while also supporting time-poor clinicians.

Read the full whitepaper ‘Patient Support Programs: Now, Near, Next’ here: https://goo.gl/rT74WG

See insights from 20 industry leaders including Sanofi, Takeda and Ipsen as they discuss:
• Using data and technology to show powerful patient experiences
• How patient insights are driving design for the most effective PSPs
• The next-gen PSPs that will be the true ‘beyond the pill’ solution

Download the whitepaper here: https://goo.gl/rT74WG

Getting patient support programs right can mean the difference between success or failure. It’s not about putting more money into it; they require upfront insight, design and ambition. Pills alone are not enough to meet the needs of patients and customers.
eyeforpharma’s latest whitepaper discusses how patient interactions can be increasingly personalized with support specific to each patient’s condition, circumstances and behavioral challenges. Get this right and you can positively impact patient outcomes while also supporting time-poor clinicians.

Read the full whitepaper ‘Patient Support Programs: Now, Near, Next’ here: https://goo.gl/rT74WG

See insights from 20 industry leaders including Sanofi, Takeda and Ipsen as they discuss:
• Using data and technology to show powerful patient experiences
• How patient insights are driving design for the most effective PSPs
• The next-gen PSPs that will be the true ‘beyond the pill’ solution

Download the whitepaper here: https://goo.gl/rT74WG

Discussions in pharma have previously centred on why it is necessary to gain patient insight, but now conversations have moved on from ‘Why are we doing it?’ to ’How do we do it?’.   34% of listeners in eyeforpharma’s recent webinar believed a ‘patient-first internal culture’ was the most important element to achieving universal patient engagement. Listen to our expert panel, including representatives from AstraZeneca, Teva and Grunenthal, give practical tips on how they are operationalising patient-first models so that they deliver, both for their companies, and for their patients. Don’t be left behind, move from the why to the how and listen to the webinar recordings here: https://goo.gl/LyN5cV